Spine BioPharma completed enrollment in its Phase 3 MODEL trial, evaluating SB-01 for chronic low back pain (CLBP) due to degenerative disc disease (DDD).
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.